Ticker Symbol: HQL

Tekla Life Sciences Investors

$20.59 - 20-12-2024 4 p.m. ET

Exchange: NEW YORK STOCK EXCHANGE INC. Country: US Currency: USD Asset Type: Common Stock CIK:0000884121

Company Profile

Tekla Life Sciences Investors is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund.

Sector: Finance and Insurance

Industry: Securities and Commodity Exchanges

Standard Industrial Classification Code (SIC code): 0

Address: 100 Federal Street, 19Th Floor

Website: www.teklacap.com/funds/hql/fund/fund-information

CEO: N/A

Tags:

Miscellaneous
Investment Trusts/Mutual Funds

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $12.26

Change: -$0.18 ( -1.45%)

Days Range: $12.23 - $12.39

Beta: 0.67

52wk. High: $14.21

52wk. Low: $11.71

Ytd. Change -7.49%

50 Day Moving Average: $12.54

200 Day Moving Average: $13.04

Shares Outstanding: 26212047

Valuation

Market Cap: 32.1B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): $1.23

Dividend Yield (TTM): 10.50%

Ex-Dividend Date: August 24, 2023